Navigation Links
A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients

in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond Transition's control, adverse events that would require clinical trials to be prematurely terminated, clinical results that indicate continuing clinical and commercial pursuit of E1-I.N.T.(TM) is not advisable, the fact that the results from completed exploratory Phase IIa clinical trials are not always indicative of those seen in future clinical trials, and the risk factors and other cautionary statements discussed in Transition's quarterly and annual filings with the Canadian commissions.

CONTACT: For further information on Transition, visitwww.transitiontherapeutics.com or contact: Dr. Tony Cruz, Chief ExecutiveOfficer, Transition Therapeutics Inc., Phone: (416) 260-7770, x.223,; Mr. Elie Farah, CFO and VP, CorporateDevelopment, Transition Therapeutics Inc., Phone: (416) 260-7770, x.203, tcruz@transitiontherapeutics.com efarah@transitiontherapeutics.com

Ticker Symbol: (Toronto:TTH.)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
7. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
8. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
9. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
10. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
11. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy

Post Your Comments:
(Date:11/25/2009)... , NEW YORK, Nov. 25 Rep... report is available in its catalogue: ,, Pai...eportlinker.com/p0164220/Pain-Management---Global-...ric drugs, emergence of pain management clinics, a...ce of growth in the pain management market. Health...
(Date:11/25/2009)... , DELFT, The Netherlands and JOHANNESB...ticals, service division and Pyxis Discovery annou...greement to jointly market both,companies, service...emistry and lead discovery expertise,will be coupl...cinal and,synthetic chemistry support to projects ...
(Date:11/25/2009)... , MOUNTAIN VIEW, Calif., Nov. 25 /PRNewswire/ ...e II/III clinical data from the Company,s PROTECT-...ion in Crohn,s disease Trial) of Traficet-EN(TM) (...n,s disease demonstrated clinical efficacy with a ...udy demonstrated evidence of clinical efficacy in ...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6U of I scientist 3A Public policy should promote family mealtimes 9845 1U of I scientist 3A Public policy should promote family mealtimes 9845 2U of I scientist 3A Public policy should promote family mealtimes 9845 3Old Colony Elder Services Collaborates with The Charity Guild of Brockton to Offer 26quot 3BSpecial Foods for Special People 26quot 3B Program 56612 1Old Colony Elder Services Collaborates with The Charity Guild of Brockton to Offer 26quot 3BSpecial Foods for Special People 26quot 3B Program 56612 2Old Colony Elder Services Collaborates with The Charity Guild of Brockton to Offer 26quot 3BSpecial Foods for Special People 26quot 3B Program 56612 3National Preparedness Month Are You Prepared 3F 56609 1National Preparedness Month Are You Prepared 3F 56609 2National Preparedness Month Are You Prepared 3F 56609 3
...Progen,Pharmaceuticals Limited (ASX:PGL; Nasdaq: P...patient enrolment in the phase 1 dose-escalation s...PG-11047 (formerly CGC-11047),for patients with ad...of PG-11047 - the lead clinical,compound in the Co...ion of,Cellgate, Inc earlier this year. The first ...
...14 Revolution Health and,EmergingMed today announ...,physicians the largest personalized cancer clinic...ed States. Individuals can quickly assess their,el...ings in a confidential,and efficient way through a...ial specialist. The service, powered by EmergingMe...
Other Medicine Technology:Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service 2
(Date:11/27/2009)..., KELOWNA, BC, Nov. 27 /PRNewswire/ - Uploadabl...eeing prime time in wellness. A combination of adv...ta upload are solving a long term concern over the... to accurately gauge and reward improved participa...logies is one of the first wellness suppliers to i...
(Date:11/27/2009)..., SAN FRANCISCO, Nov. 27 /PRNewswire-FirstCall/...unced that Blair Lambert, CFO/COO, will present at...be held at the May Fair Hotel in London, England, ... ,, To listen to a live broadcast of The Gymbor...lease log on to www.gymboree.com, click on "Our Co...
(Date:11/27/2009)..., KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-F... SHMR ) ( "Shamir" ), a leading provider of innov...ns market, announced today that its board of direc...gregate amount of US$ 10 million (approximately NI...resentative rate of exchange), or approximately US...
(Date:11/27/2009)...g rates to bring unprecedented medical, economic b...27 (HealthDay News) -- The number of people with d... over the next 25 years, a new study predicts. ,... million people with the disease, up from 23.7 mil...eating people with diabetes will triple, the study...
(Date:11/27/2009)... Multi-purpose bilingual colori...ned for use by the business community to educate -... subjects from Safety issues to Dinosuars to ABC,S... Saint Louis, MO (PRWEB) November 27, 2009 --...ronics or toys to keep them busy any hour of the d...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...als a SARS vaccine may be on the horizon. Research...promising results from a study involving eight Afr...munized against the SARS virus using an intranasal...us that causes SARS. The other four monkeys did no...
...s that heart attacks don't just strike overweight ...rding to a study from // The Cincinnati Children's... causes an increase in the wall thickness of the l...individual. Researchers say the thicker a patie...
...n of developing Alzheimer’s disease is a drop in b...esearch.// Results from previous research on t...r’s disease have been conflicting. In a recent stu...lder. The participants had no signs of dementia wh...
... could make it hard for a woman to get pregnant, ...y .// For the study researchers looked at how ...equent embryo implantation in the womb and develop... in their development. Some mice were fed a diet c...
...d slow down the progression of HIV, according to n...ost way to delay the progression of this deadly di...tamins may play a role in the progression of HIV. ...were infected with HIV. The women were given daily...
... now control their blood sugar without gaining wei...hers according to a new study.// In an effort to a... has resulted in a variety of drugs that lower blo...their weight. Researchers analyzed the safety a...
Other Medicine News:
...Color video camera with direct digital output. Thr...d fluorescence applications. Olympus wide array of... image quality and flexibility you need for an eff...vide a high-resolution, real-time image of your sp...
...The PM30 is a premium photomicrography system tha...phs of even the most difficult specimens. Designed...de solution to the complex problem of fluorescence...exposure control, the system utilizes special prog...
...The AxioCam HR from Carl Zeiss was developed for t... does it generate needle-sharp, color-fast images ...d to work with the microscope and fully integrated... to work more productively, as digital technology ...
...High performance digital FireWire camera system fo...80 Digital Camera system provides images of the hi...under low illumination, users can expect perfect i... integrated Peltier cooling and innovative readout...
Medicine Products: